. Author manuscript; available in PMC: 2010 Sep 7.

Published in final edited form as: Arch Intern Med. 2009 Jul;169(14):1317–1324. doi: 10.1001/archinternmed.2009.229

Table 4.

Patterns of anticholinergic use during follow-up and incident dementia (Cox model with delayed entry)*

	HR^† (CI)	p
All dementia (n=177)	n=6463
Discontinuing	1.28 [0.59–2.76]	0.53
Continuing	1.65 [1.00–2.73]	0.05
Alzheimer’s dementia (n=113)	n=6399
Discontinuing	1.72 [0.74–3.99]	0.21
Continuing	1.94 [1.01–3.72]	0.05

^†

adjusted for centre, age, sex, education, BMI, alcohol, tobacco and caffeine intake, mobility, hypercholesterolemia, ApoE, diabetes, asthma, depression, ischemic pathologies, Parkinson’s disease and hypertension.